These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1305962)

  • 1. Circadian variations of phenacetin metabolism in rats in vivo and in vitro.
    Starek A
    Pol J Pharmacol Pharm; 1992; 44(6):663-70. PubMed ID: 1305962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipyretic action of aniline derivatives in rats during different parts of the day].
    Rachtan R; Starek A
    Folia Med Cracov; 1990; 31(4):289-302. PubMed ID: 2135897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of phenacetin O-deethylase in rat liver: effect of inducers and inhibitors in vivo.
    Starek A
    Pol J Occup Med Environ Health; 1991; 4(1):67-75. PubMed ID: 1818647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 3-methylcholanthrene-mimetic effect of 4,4'-dichlorobiphenyl-treatment on phenacetin-induced hepatic glutathione depletion and liver microsomal phenacetin O-deethylation in rats.
    van Bree L; Redegeld FA; de Vries J
    Toxicology; 1986 Dec; 42(2-3):259-74. PubMed ID: 3099430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
    [No Abstract]   [Full Text] [Related]  

  • 6. Circadian-time rhythm of hepatic protein kinase C of rats pretreated with phenobarbital.
    Möritz KU; Walter R; Franke G; Siegmund W
    Pharmazie; 1995 Mar; 50(3):211-3. PubMed ID: 7732053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the activity of P450 enzymes in rats: use of the single marker or combined drug administration.
    Jurica J; Kyr M; McCaskey Hadasova E; Tomandl J
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():92-5. PubMed ID: 20027151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rate of aniline metabolism in vivo in rats exposed to aniline and drugs.
    Wiśniewska-Knypl JM; Jabłońska JK
    Xenobiotica; 1975 Aug; 5(8):511-9. PubMed ID: 1166665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenacetin O-deethylase activity of the rat: strain differences and the effects of enzyme-inducing compounds.
    Kahn GC; Rubenfield M; Davies DS; Boobis AR
    Xenobiotica; 1987 Feb; 17(2):179-87. PubMed ID: 3564533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of phenacetin in V79 Chinese hamster cell cultures expressing rat liver cytochrome P4501A2 compared to isolated rat hepatocytes.
    Jensen KG; Loft S; Doehmer J; Poulsen HE
    Biochem Pharmacol; 1993 Mar; 45(5):1171-3. PubMed ID: 8461047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effect of diallyl sulfide and cimetidine on phenacetin metabolism and bioavailability in rat.
    Szutowski MM; Zalewska K; Jadczak M; Marek M
    Acta Biochim Pol; 2002; 49(1):249-56. PubMed ID: 12136947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic rate of phenacetin and of paracetamol in dogs before and after treatment with phenobarbital or skf 525 A.
    Kampffmeyer HG
    Biochem Pharmacol; 1974 Feb; 23(3):713-24. PubMed ID: 4150814
    [No Abstract]   [Full Text] [Related]  

  • 13. [Susceptibility of rats to benzene during morning and evening].
    Starek A; Lepiarz W; Baran J
    Folia Med Cracov; 1990; 31(4):279-87. PubMed ID: 2135896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermolecular interactions of antimicrobial fluoroquinolones with purified rat liver CYP1A2 studied by proton nuclear magnetic resonance spectroscopy.
    Mizuki Y; Yamamoto K; Yamaguchi T; Fujii T; Miyazaki H; Ohmori H
    Xenobiotica; 1996 Oct; 26(10):1057-66. PubMed ID: 8905919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters.
    Nohmi T; Mizokami K; Kawano S; Fukuhara M; Ishidate M
    Jpn J Cancer Res; 1987 Feb; 78(2):153-61. PubMed ID: 3104258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
    J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism.
    Chang TK; Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):270-5. PubMed ID: 7616408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
    Hietanen E; Ahotupa M; Heikelä A; Laitinen M
    Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine?
    Kahn GC; Boobis AR; Brodie MJ; Toverud EL; Murray S; Davies DS
    Br J Clin Pharmacol; 1985 Jul; 20(1):67-76. PubMed ID: 4027138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.